29415-97-2

Basic information

• Product Name: Methyl 3-bromo-4-hydroxybenzoate
• Synonyms: Methyl 3-bromo-4-hydroxybenzoa;EOS-61539
• CAS NO: 29415-97-2
• Molecular Formula: C₈H₇BrO₃
• Molecular Weight: 231.044
• Mol File: 29415-97-2.mol
• Article Data: 20

Chemical Properties

• Melting Point: 108-110℃
• Boiling Point: 283.1°C at 760 mmHg
• Flash Point: 125°C
• Appearance: /
• Density: 1.627g/cm³
• Vapor Pressure: 0.00188mmHg at 25°C
• Refractive Index: 1.585
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 6.82±0.18(Predicted)
• CAS DataBase Reference: Methyl 3-bromo-4-hydroxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-bromo-4-hydroxybenzoate(29415-97-2)
• EPA Substance Registry System: Methyl 3-bromo-4-hydroxybenzoate(29415-97-2)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 29415-97-2(Hazardous Substances Data)

Usage

Uses

A reactant used in the preparation of selective inhibitors. In unsymmetrical Ullman reaction between methyl 5bromovanillate (II) and methyl 3-bromo-4-hydroxybenzoate (III) yielded all the three possible dicarbomethoxy-dibenzo-pdioxms which were separated by repeated chromatography over silica gel. A phosphorus- and bromine-containing bifunctional monomer has been prepared from bis(chloromethyl)methylphosphine oxide and the sodium salt of methyl 3-bromo-4-hydroxybenzoate.

InChI:InChI=1/C8H7BrO3/c1-12-8(11)5-2-3-7(10)6(9)4-5/h2-4,10H,1H3

Upstream product

• 67-56-1 methanol 
• 14348-41-5 3-bromo-4-hydroxy-benzoic acid 
• 67201-23-4 methyl 2-trimethylsilyl-4-trimethylsilyloxycyclohex-3-enecarboxylate 
• 99-96-7 4-hydroxy-benzoic acid 
• 66548-21-8 di(methyl)tert-butyl(methoxy)silane 
• 123-08-0 4-hydroxy-benzaldehyde 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 886643-00-1 4-allyloxy-3-bromo-benzoic acid 
• 35450-37-4 methyl 3-bromo-4-methoxybenzoate 
• 122289-46-7 methyl-3-bromo-4-(dodecyloxy)benzoate 
• 325147-52-2 2-(2-bromo-4-carboxylic acid methyl ester phenoxy)-1-tert-butyldimethylsiloxyethane 
• 213598-10-8 methyl 3-bromo-4-isopropoxybenzoate 
• 54110-86-0 2-(2-bromo-4-carboxylic acid methyl ester phenoxy)ethanol 
• 20197-75-5 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid methyl ester 
• 554432-57-4 3-(4-hydroxy-3-octylbenzoyl)-2-benzothiazolone 
• 711012-11-2 (3-bromo-4-methoxymethoxy-benzyloxy)-tert-butyl-dimethyl-silane 
• 219565-74-9 3'-(2-propenyl)-5-propyl-(1,1'-biphenyl)-2,4'-diol 
• 35354-74-6 Honokiol 
• 672922-60-0 {4-Methoxymethoxy-3-[(E)-3-methyl-5-((4aS,8aS)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl)-pent-2-enyl]-phenyl}-methanol 
• 672922-61-1 4-Methoxymethoxy-3-[(E)-3-methyl-5-((4aS,8aS)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-naphthalen-1-yl)-pent-2-enyl]-benzaldehyde 
• 672922-58-6 2-(3-bromo-4-methoxymethoxy-benzyloxy)-tetrahydro-pyran 

Relevant articles and documents

IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE

Provided is an iridium complex compound represented by formula (1) below. [Ir is an iridium atom. C1 to C6 are carbon atoms. N1 and N2 are nitrogen atoms. R1 to R4 are each a hydrogen atom

CARBOXY SUBSTITUTED (HETERO) AROMATIC RING DERIVATIVES AND PREPARATION METHOD AND USES THEREOF

Carboxy-substituted (hetero)aryl derivatives, pharmaceutical compositions comprising these compounds, and methods of preparing such compounds and compositions are provided. The compounds or compositions are useful in inhibiting xanthine oxidase and urate anion transporter 1, and also can be used in the treatment or prevention of diseases associated with high blood uric acid level in mammals, especially humans.

TRICYCLIC COMPOUND AND USE THEREOF

The present invention relates to: a compound selected from the group consisting of a tricyclic compound having the structure of formula I, a pharmaceutically acceptable salt, an isomer, a solvate and a precursor thereof; and a use thereof. The compound effectively controls GPR40, and thus, can be effectively used for the prophylaxis or treatment of diseases associated with GPR40, for example, diabetes and many other diseases.